RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW
RXIIW was delisted on the 16th of November, 2018.
4 hedge funds and large institutions have $1.8M invested in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
1% less capital invested
Capital invested by funds: $1.82M → $1.8M (-$16K)
20% less funds holding
Funds holding: 5 → 4 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$14K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$559 |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$82 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $1.24M | -$82 | -500 | -0% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $288K | -$559 | -3,400 | -0.2% |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $273K | – | – | – |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $4K | – | – | – |
|
|
5
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$14K | -84,628 | Closed |
|
RXIIW Hedge Fund Activity: Q4 2017 in Review
4 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) for Q4 2017, worth a combined $1.8M — down 0.88% from $1.82M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RXIIW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $14K sold.
- 4 institutional investors held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) as of Q4 2017, down from 5 in Q3 2017.
- Funds reported $1.8M of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 stock for Q4 2017, down 0.88% quarter-over-quarter.
- 0 funds opened new RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 seller in Q4 2017 was Hudson Bay Capital Management, an estimated $14K sold.
Based on aggregated 13F filings for Q4 2017.